Repare Therapeutics Inc. - stock earnings
RPTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -28.0 million USD | 13.0 million USD |
| 2023Q3 | -18.9 million USD | 2.2 million USD |
| 2023Q2 | -11.9 million USD | 30.2 million USD |
| 2023Q1 | -34.9 million USD | 5.7 million USD |
| 2022Q4 | -31.7 million USD | 18.2 million USD |
| 2022Q3 | 75.5 million USD | 112.5 million USD |
| 2022Q2 | -38.1 million USD | 679000 USD |
| 2022Q1 | -34.8 million USD | 408000 USD |
| 2021Q4 | -28.3 million USD | 6.9 million USD |
| 2021Q3 | -30.9 million USD | 278000 USD |
| 2021Q2 | -26.3 million USD | 279000 USD |
| 2021Q1 | -21.4 million USD | 166000 USD |
| 2020Q4 | -15.3 million USD | 135000 USD |
| 2020Q3 | -13.8 million USD | ? USD |
| 2020Q2 | -11.8 million USD | ? USD |
| 2020Q1 | -12.6 million USD | ? USD |
| 2019Q4 | -8.3 million USD | ? USD |
| 2019Q3 | -7.7 million USD | ? USD |
| 2019Q2 | -6.4 million USD | ? USD |
| 2019Q1 | -4.8 million USD | ? USD |
RPTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -93.8 million USD | 51.1 million USD |
| 2022 | -29.0 million USD | 131.8 million USD |
| 2021 | -106.9 million USD | 7.6 million USD |
| 2020 | -53.4 million USD | 135000 USD |
| 2019 | -27.2 million USD | ? USD |
| 2018 | -14.3 million USD | ? USD |
| 2017 | -7.8 million USD | ? USD |
RPTX
Price: $3.45
52 week price:
Earnings Per Share: -2.23 USD
P/E Ratio: -3.64
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 108000
Market Capitalization: 164.5 million